CMX001 in Post-transplant Patients With BK Virus Viruria

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Viruria
Interventions
DRUG

Placebo

DRUG

Brincidofovir

Trial Locations (15)

10029

Mt. Sinai Medical Center, New York

15260

University of Pittsburgh, Pittsburgh

19024

Fred Hutchinson Cancer Research Center, Seattle

21287

Johns Hopkins Medical Institutions, Baltimore

27157

Wake Forest University Health Sciences, Winston-Salem

27599

UNC Kidney Center, Chapel Hill

48109

University of Michigan, Ann Arbor

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

70112

Tulane Center for Abdominal Transplant, New Orleans

94115

California Pacific Medical Center, San Francisco

94143-0780

University of California, San Francisco, San Francisco

02115

Beth Israel Deaconess Medical Center, Boston

05405

University of Vermont, Burlington

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY